https://www.biomedcentral.comArticles: Tokyo Women's Medical University//rrtjournal.biomedcentral.com/articles/10.1186/s41100-025-00614-xApproximately 95% of patients with idiopathic nephrotic syndrome (INS) have a favorable prognosis, though 4–5% progress to end-stage renal disease. The recurrence rate of INS following kidney transplantation i...Case ReportSat, 05 Apr 2025 00:00:00 GMT//rrtjournal.biomedcentral.com/articles/10.1186/s41100-025-00614-xRyoichi Miyazaki, Kyoko Miyagi, Tatsuhito Miyanaga, Yoko Shirai, Kenichiro Miura, Motoshi Hattori, Satoshi Hara, Kiyoaki Ito, Ichiro Mizushima and Yasunori Iwata2025-04-05T00:00:00Z//bmcprimcare.biomedcentral.com/articles/10.1186/s12875-025-02711-6People living with type 2 diabetes mellitus (T2DM) are likely to develop oral health problems, and vice versa. The burden of oral health and T2DM is increasing, especially in low- and middle-income countries. ...ResearchSat, 29 Mar 2025 00:00:00 GMT//bmcprimcare.biomedcentral.com/articles/10.1186/s12875-025-02711-6Yuriko Harada, Prapti Giri, Dilip Prajapati, Haruka Sakamoto, Tomohiko Sugishita and Lal Rawal2025-03-29T00:00:00Z//bmcsurg.biomedcentral.com/articles/10.1186/s12893-025-02843-7Mediastinal tumors (MTs) develop in various sites within the thoracic cavity, and the robotic surgical approach for MTs varies depending on the tumor location. This study aimed to assess the optimal approach f...ResearchWed, 26 Mar 2025 00:00:00 GMT//bmcsurg.biomedcentral.com/articles/10.1186/s12893-025-02843-7Hiroe Aoshima, Motoka Omata, Hiroaki Shidei, Akira Ogihara, Shota Mitsuboshi, Tamami Isaka, Takako Matsumoto and Masato Kanzaki2025-03-26T00:00:00Z//jintensivecare.biomedcentral.com/articles/10.1186/s40560-025-00785-zNutrition therapy is important in the management of critically ill patients and is continuously evolving as new evidence emerges. The Japanese Critical Care Nutrition Guideline 2024 (JCCNG 2024) is specific to...ReviewFri, 21 Mar 2025 00:00:00 GMT//jintensivecare.biomedcentral.com/articles/10.1186/s40560-025-00785-zKensuke Nakamura, Ryo Yamamoto, Naoki Higashibeppu, Minoru Yoshida, Hiroomi Tatsumi, Yoshiyuki Shimizu, Hiroo Izumino, Taku Oshima, Junji Hatakeyama, Akira Ouchi, Rie Tsutsumi, Norihiko Tsuboi, Natsuhiro Yamamoto, Ayumu Nozaki, Sadaharu Asami, Yudai Takatani…2025-03-21T00:00:00Z//bmcmedicine.biomedcentral.com/articles/10.1186/s12916-025-03981-8Long-term cost-effectiveness analyses of health behaviour interventions to effectively manage type 2 diabetes mellitus (T2DM) in low-income countries are crucial for minimising economic burden and optimising r...ResearchTue, 11 Mar 2025 00:00:00 GMT//bmcmedicine.biomedcentral.com/articles/10.1186/s12916-025-03981-8Padam Kanta Dahal, Corneel Vandelanotte, Lal Rawal, Rashidul Alam Mahumud, Grish Paudel, Melanie Lloyd, Yeji Baek, Biraj Karmacharya, Tomohiko Sugishita and Zanfina Ademi2025-03-11T00:00:00Z//bmcnephrol.biomedcentral.com/articles/10.1186/s12882-025-04046-xCyanotic nephropathy (CN) is a known complication of cyanotic congenital heart disease (CCHD). However, many aspects of its pathophysiology remain unclear.Case ReportMon, 03 Mar 2025 00:00:00 GMT//bmcnephrol.biomedcentral.com/articles/10.1186/s12882-025-04046-xYusuke Ushio, So Hirata, Shun Manabe, Mayuko Suyama, Ayano Tanaka, Momoko Seki, Haruka Kato, Kana Nomura, Anna Nakai, Hitoko Sumori, Yuki Kawaguchi, Shizuka Kobayashi, Shiho Makabe, Hiroshi Kataoka, Naoko Itoh, Sekiko Taneda…2025-03-03T00:00:00Z//ojrd.biomedcentral.com/articles/10.1186/s13023-025-03597-4Spinal muscular atrophy (SMA) is a severe genetic neuromuscular disease caused by insufficient functional survival motor neuron protein (SMN). The SMN expression level in the spinal cord is highest during the ...ResearchFri, 28 Feb 2025 00:00:00 GMT//ojrd.biomedcentral.com/articles/10.1186/s13023-025-03597-4Noriko Otsuki, Tamaki Kato, Mamoru Yokomura, Mari Urano, Mari Matsuo, Emiko Kobayashi, Kazuhiro Haginoya, Hiroyuki Awano, Yasuhiro Takeshima, Toshio Saito and Kayoko Saito2025-02-28T00:00:00Z//stemcellres.biomedcentral.com/articles/10.1186/s13287-025-04195-8Hemophilia B is an inherited disorder caused by a mutation in the FIX gene, which results in insufficient blood clotting factor IX (FIX) production from hepatocytes. Currently, there are no treatments for hemo...ResearchSun, 23 Feb 2025 00:00:00 GMT//stemcellres.biomedcentral.com/articles/10.1186/s13287-025-04195-8Delger Bayarsaikhan, Govigerel Bayarsaikhan, Jaesuk Lee, Teruo Okano, Kyungsook Kim and Bonghee Lee2025-02-23T00:00:00Z//bmcmedinformdecismak.biomedcentral.com/articles/10.1186/s12911-025-02915-xIntraoperative imaging devices (i-ID), such as intraoperative optical coherence tomography (iOCT), offer surgeons critical insights previously unobservable, enhancing surgical precision and safety. Despite the...ResearchMon, 10 Feb 2025 00:00:00 GMT//bmcmedinformdecismak.biomedcentral.com/articles/10.1186/s12911-025-02915-xHiroyuki Suzuki, Yusuke Tsuboko, Manabu Tamura, Ken Masamune and Kiotaka Iwasaki2025-02-10T00:00:00Z//ojrd.biomedcentral.com/articles/10.1186/s13023-025-03568-9Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease. Most patients with SMA have a mutation in the survival motor neuron 1 (SMN1) gene on chromosome 5q. With current genetic testing, SMN...ResearchFri, 07 Feb 2025 00:00:00 GMT//ojrd.biomedcentral.com/articles/10.1186/s13023-025-03568-9Tamaki Kato, Mamoru Yokomura, Yutaka Osawa, Kensuke Matsuo, Yuji Kubo, Taihei Homma and Kayoko Saito2025-02-07T00:00:00Z//bmcophthalmol.biomedcentral.com/articles/10.1186/s12886-024-03827-6To report a case of intraocular inflammation (IOI) after intravitreal injection of aflibercept 8 mg for treatment-refractory neovascular age-related macular degeneration.Case ReportThu, 23 Jan 2025 00:00:00 GMT//bmcophthalmol.biomedcentral.com/articles/10.1186/s12886-024-03827-6Nozomu Hashiya, Ichiro Maruko, Yuri Miyaguchi, Ruka Maruko, Taiji Hasegawa and Tomohiro Iida2025-01-23T00:00:00Z//jphcs.biomedcentral.com/articles/10.1186/s40780-024-00402-5In the dose titration of transdermal fentanyl to prevent unrelieved pain, it is important to consider not only dose adjustment, but also the titration period, which is influenced by the time required to reach ...Research articleWed, 18 Dec 2024 00:00:00 GMT//jphcs.biomedcentral.com/articles/10.1186/s40780-024-00402-5Satoshi Mizuno, Makiko Takabayashi, Hiroko Makihara, Kazuhiro Ogai, Kei Tsukui, Yuriko Ito, Takahiro Kawakami, Yusuke Hara, Arimi Fujita, Yoshihiro Tokudome, Tomoko Akase, Yukio Kato, Tsutomu Shimada and Yoshimichi Sai2024-12-18T00:00:00Z//ghrp.biomedcentral.com/articles/10.1186/s41256-024-00364-zPrevention of type 2 diabetes is becoming an urgent public health concern in low and middle-income countries (LMICs). However, there is currently no evidence of a cost-effective approach of health behaviour in...ResearchTue, 17 Dec 2024 00:00:00 GMT//ghrp.biomedcentral.com/articles/10.1186/s41256-024-00364-zPadam Kanta Dahal, Zanfina Ademi, Lal Rawal, Rashidul Alam Mahumud, Grish Paudel, Biraj Karmacharya, Haruka Sakamoto, Tomohiko Sugishita and Corneel Vandelanotte2024-12-17T00:00:00Z//bmcnephrol.biomedcentral.com/articles/10.1186/s12882-024-03849-8Iron deficiency is a major contributor to anaemia in chronic kidney diseases. The association of anaemia and iron deficiency with health-related quality of life in Japanese patients with non-dialysis chronic k...ResearchTue, 19 Nov 2024 00:00:00 GMT//bmcnephrol.biomedcentral.com/articles/10.1186/s12882-024-03849-8Reiko Okubo, Tomohiro Ohigashi, Masahide Kondo, Ryoya Tsunoda, Hirayasu Kai, Chie Saito, Junichi Hoshino, Hirokazu Okada, Ichiei Narita, Shoichi Maruyama, Takashi Wada and Kunihiro Yamagata2024-11-19T00:00:00Z//jintensivecare.biomedcentral.com/articles/10.1186/s40560-024-00755-xExtracorporeal membrane oxygenation (ECMO) might be required as a treatment option in patients with critical pulmonary embolism (PE). However, the clinical features and outcomes of the use of ECMO for critical...ResearchTue, 05 Nov 2024 00:00:00 GMT//jintensivecare.biomedcentral.com/articles/10.1186/s40560-024-00755-xKensuke Takabayashi, Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, Kazuhisa Kaneda, Yuji Nishimoto, Nobutaka Ikeda, Yohei Kobayashi, Satoshi Ikeda, Kitae Kim, Moriaki Inoko, Toru Takase, Shuhei Tsuji, Maki Oi, Takuma Takada, Kazunori Otsui…2024-11-05T00:00:00Z//rrtjournal.biomedcentral.com/articles/10.1186/s41100-024-00576-6Heart failure (HF) is a frequent complication and the main cause of death in patients on dialysis. HF with preserved ejection fraction (HFpEF) is a complicated syndrome that manifests as diastolic dysfunction ...ReviewMon, 14 Oct 2024 00:00:00 GMT//rrtjournal.biomedcentral.com/articles/10.1186/s41100-024-00576-6Kosaku Nitta and Koichiro Kinugawa2024-10-14T00:00:00Z//bpsmedicine.biomedcentral.com/articles/10.1186/s13030-024-00317-5Low-grade systemic inflammation may be a key player in the immune activation that has been reported for mental health deterioration. We hypothesised that elevated serum levels of inflammatory cytokines increas...ResearchWed, 02 Oct 2024 00:00:00 GMT//bpsmedicine.biomedcentral.com/articles/10.1186/s13030-024-00317-5Hirohito Tsuboi, Hiroyuki Sakakibara, Yuuki Minamida-Urata, Hiromasa Tsujiguchi, Akinori Hara, Keita Suzuki, Sakae Miyagi, Masaharu Nakamura, Chie Takazawa, Takayuki Kannon, Jiaye Zhao, Yukari Shimizu, Aki Shibata, Aya Ogawa, Fumihiko Suzuki, Yasuhiro Kambayashi…2024-10-02T00:00:00Z//bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-024-06031-4We report the final results of treatment with aripiprazole, blonanserin, and paliperidone from the Japan Useful Medication Program for Schizophrenia (JUMPs), a 104-week naturalistic study.ResearchThu, 05 Sep 2024 00:00:00 GMT//bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-024-06031-4Jun Ishigooka, Kazuyuki Nakagome, Tetsuro Ohmori, Nakao Iwata, Ken Inada, Jun-ichi Iga, Taro Kishi, Kiyoshi Fujita, Yuka Kikuchi, Toshiaki Shichijo, Hideaki Tabuse, Shotatsu Koretsune, Hiroshi Terada, Haruko Terada, Toshifumi Kishimoto, Yuichiro Tsutsumi…2024-09-05T00:00:00Z//rrtjournal.biomedcentral.com/articles/10.1186/s41100-024-00567-7In Japan dialyzers are classified as type I, II, III, IV, or V on the basis of the β2-microglobulin clearance. In 2023, Type V dialyzers were defined as super high-flux membrane dialyzers. Herein, we investigate ...ResearchThu, 22 Aug 2024 00:00:00 GMT//rrtjournal.biomedcentral.com/articles/10.1186/s41100-024-00567-7Masanori Abe, Kan Kikuchi, Eiichiro Kanda, Atsushi Wada, Shigeru Nakai and Norio Hanafusa2024-08-22T00:00:00Z//jeccr.biomedcentral.com/articles/10.1186/s13046-024-03163-zBetel quid and its major ingredient, areca nut, are recognized by IARC as major risk factors in oral cancer development. Areca nut extract (ANE) exposure has been linked to OPMD progression and malignant trans...ResearchTue, 20 Aug 2024 00:00:00 GMT//jeccr.biomedcentral.com/articles/10.1186/s13046-024-03163-zShyng-Shiou F. Yuan, Leong-Perng Chan, Hieu D. H. Nguyen, Chang-Wei Su, Yuk-Kwan Chen, Jeff Yi-Fu Chen, Shigetaka Shimodaira, Stephen Chu‐Sung Hu, Steven Lo and Yen-Yun Wang2024-08-20T00:00:00Z